Northrop Grumman Q4 sales rise 10% to $11.7 billion; 2026 EPS guided to $27.40-$27.90
Northrop Grumman reported fourth-quarter 2025 sales up 10% to $11.7 billion and full-year 2025 sales of $42.0 billion, with full-year MTM-adjusted EPS of $26.34 versus $26.08 in 2024. The company guided 2026 sales of $43.5 billion to $44.0 billion and MTM-adjusted EPS of $27.40 to $27.90, consistent with its October outlook, and reported a record backlog of $95.7 billion.
Key points
- Q4 2025 sales rose to $11.7 billion from $10.7 billion; full-year sales were $42.0 billion, up 2%
- Full-year 2025 diluted EPS was $29.08, including a $394 million after-tax mark-to-market pension benefit; MTM-adjusted EPS was $26.34
- 2026 guidance: sales of $43.5 billion to $44.0 billion, MTM-adjusted EPS of $27.40 to $27.90, and free cash flow of $3.1 billion to $3.5 billion
- Full-year 2025 segment operating income fell 4%, mainly due to a $477 million B-21 loss provision in the first quarter
The filing
Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 27, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.